Thailand announced that human trials on its locally developed coronavirus vaccine will begin in October after the second round of trials on monkeys showed positive results
Higher Education, Science, Research and Innovations Minister Suwit Mesinsee posted on Facebook today that the vaccine candidate produced a large number of virus antibodies in the bloodstreams of the monkeys.
Chulalongkorn University, which is leading the research, next will seek volunteers for the Phase 1 tests, which simply check that the vaccine is safe and produces no serious side effects. A Phase 2 a larger trial later will determine if it actually produces sufficient levels of antibodies.
Thailand has reported 3,217 cases of Covid-19 – including one on Sunday – but no local transmission for a day short of seven weeks. However, it has been moving rapidly to develop its own coronavirus tests and vaccine to prepare for an expected second wave.
Sunday’s reported case was a 39-year-old man who had returned from Japan on June 30 and tested positive for the coronavirus on July 10, although he showed no symptoms. Sunday also saw two more recoveries.
Total Covid-19 cases in Thailand stand at 3,217, 3,088 recoveries and 58 deaths.